Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upneeq vs Lumify in Acquired Ptosis
NCT07390578Phase 4Not yet recruiting
- Sponsor
- Duke University
- Start
- Dec 2026
- Primary completion
- Aug 2027
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of oxymetazoline, brimonidine tartrate + sodium hyaluronate in acquired ptosis, sponsored by Duke University. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
oxymetazolinebrimonidine tartrate + sodium hyaluronate
03
Conditions
acquired ptosis
Beyond the preview
Go deeper on NCT07390578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07390578.